Biofil Chemicals and Pharmaceuticals Limited (BOM:524396)

India · Delayed Price · Currency is INR

32.65

+0.67 (2.10%)

At close: Jul 27, 2026

BOM:524396 Financials Overview

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	314.78	314.78	335.82	404.09	300.35	223.82
Revenue Growth	-6.27%	-6.27%	-16.89%	34.54%	34.19%	-37.50%
Gross Profit	51.91	51.91	25.67	27.48	25.63	28.66
Operating Income	34.6	34.6	7.29	9	8.34	10.34
Net Income	27.86	27.86	5.58	7.09	5.6	6.98
Earnings Per Share	1.71	1.71	0.34	0.44	0.34	0.43
EPS Growth	402.94%	402.94%	-21.98%	28.17%	-20.77%	-43.74%

Revenue by Segment

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024
Pharma Division	189.63	189.63	266.6	278.68
Chemical Division	94.32	94.32	67.42	121.67
Total	283.95	283.95	334.02	400.35

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	33.26	33.26	2.55	22.84	0.38	1.45
Total Debt	30.2	30.2	4.71	4.39	5.22	4.65
Net Cash (Debt)	3.06	3.06	-2.16	18.45	-4.85	-3.2
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	0.19	0.19	-0.13	1.13	-0.30	-0.20

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	-6.05	-6.05	-19.24	23.94	-1.12	-2.2
Capital Expenditures	-2.01	-2.01	-1	-0.23	-0.11	-0.7
Free Cash Flow	-8.05	-8.05	-20.24	23.71	-1.22	-2.9
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Margin	16.49%	16.49%	7.64%	6.80%	8.53%	12.80%
Operating Margin	10.99%	10.99%	2.17%	2.23%	2.78%	4.62%
Pretax Margin	10.96%	10.96%	2.19%	2.14%	2.64%	4.53%
Profit Margin	8.85%	8.85%	1.66%	1.75%	1.87%	3.12%
FCF Margin	-2.56%	-2.56%	-6.03%	5.87%	-0.41%	-1.29%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 28, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	18.95	15.12	120.02	138.51	120.34	134.68
P/FCF Ratio	-	-	-	41.43	-	-
PS Ratio	1.68	1.34	1.99	2.43	2.25	4.20